T[he]{.smallcaps} Golgi complex is involved in posttranslational modification of newly synthesized proteins and serves as the main sorting station for protein and vesicular traffic ([@B15]; [@B16]). Calcium is well known to be essential for cell signaling ([@B50]; [@B32]) but also for cell processes such as protein processing and membrane traffic to and through the Golgi ([@B11]; [@B26]; [@B13]). Recently the Golgi has been identified as a Ca^2+^-enriched compartment using ion microscopy and electron energy loss spectroscopy-electron spectroscopic imaging (EELS-ESI) ([@B9]; [@B21]; [@B40]). Ca^2+^ can be released from the Golgi by the Ca^2+^ ionophore A23187 ([@B9]), the Ca^2+^ channel blocker La^3+^ ([@B56]), and histamine, an agonist known to be coupled to IP~3~ generation ([@B41]). How the high level of Ca^2+^ in the Golgi is maintained is unknown at present.

The ER Ca^2+^ pool (or Ca^2+^ store) has been studied more extensively and is known to be maintained by organelle-associated Ca^2+^ ATPase (Ca^2+^ pumps) and lumenal Ca^2+^-binding proteins of which there are many ([@B3]; [@B32]). There is also evidence for the existence of Ca^2+^ pumps on the Golgi based on ATP-dependent Ca^2+^ uptake into mammalian ([@B4]; [@B23]; [@B37]; [@B53]) and yeast ([@B46]) Golgi fractions. Both sarcoplasmic/ER calcium ATPase (SERCA)^1^ and plasma membrane calcium ATPase en route to the plasma membrane are essential for Ca^2+^ uptake into isolated Golgi fractions ([@B47]). However, information on Golgi calcium-binding proteins is still limited and the detailed mechanisms of Ca^2+^ uptake, storage, and release from the Golgi apparatus remain to be elucidated. Previously, we demonstrated that CALNUC (nucleobindin) ([@B34]; [@B54]), a Golgi resident protein that faces the Golgi lumen, is the major Ca^2+^-binding protein in the Golgi based on ^45^Ca^2+^ overlay ([@B29]).

In this study we have investigated the role of CALNUC in establishing the Golgi Ca^2+^ pool in vivo by examining the effects of overexpression of CALNUC on Ca^2+^ uptake. We provide direct evidence that CALNUC possesses high affinity/low capacity Ca^2+^ binding properties and binds Ca^2+^ in the Golgi in vivo. The finding that the majority of the Ca^2+^ sequestered by overexpressed CALNUC is released by thapsigargin (Tg), ATP, and IP~3~ provides additional in vivo evidence for the existence of SERCA and inositol 1, 4, 5 trisphosphate receptor (IP~3~R) on the Golgi. CALNUC together with SERCA and IP~3~R on Golgi membranes constitute a cellular Ca^2+^ pool in the Golgi which may have distinct functions.

Materials and Methods {#MaterialsMethods}
=====================

Materials
---------

Polyclonal antibody (F-5059) against full-length, recombinant CALNUC was generated and affinity purified as previously described ([@B29]). Polyclonal anti--α-mannosidase II (Man II) was prepared as described ([@B52]). Monoclonal anti--Man II (53FC3) and polyclonal antibody against denatured Man II were gifts from Drs. B. Burke (University of Alberta, Alberta, Canada) and K. Moremen (University of Georgia, Athens, GA), respectively. Monoclonal anti--mouse IP~3~R-1 (18A10) was kindly provided by Drs. A. Miyawaki and K. Mikoshiba (University of Tokyo, Tokyo, Japan) ([@B20]). Polyclonal antibody against calnexin was a gift from Dr. J.J.M. Bergeron (McGill University, Montreal, Canada). Cross-absorbed Texas red--conjugated donkey anti--rabbit F(ab′)~2~ was obtained from Jackson ImmunoResearch Laboratories, and affinity-purified goat anti--rabbit IgG (H+L) conjugated to HRP was from Bio-Rad. ^45^CaCl~2~ was obtained from NEN Life Science Products. Supersignal chemiluminescent reagent was purchased from Pierce. All chemical reagents were from Sigma Chemical Co. except as indicated.

Preparation and Purification of His6-CALNUC
-------------------------------------------

Full-length CALNUC cDNA was amplified by PCR using 5′-CGCGCGGCAGCCATATGCCTACCTCTGTG-3′ and 5′-CGGAATTCGGATCCTTATAAATGCTGAGAATC-3′ as primers. PCR was carried out using 100 pmol of each primer, 2 ng CALNUC cDNA, 200 μM dNTP, 2.5 U PFU polymerase (Stratagene), and PCR reaction buffer in a total volume of 50 μl. PCR products were purified using a QIAquick PCR Purification kit (Qiagen) and subcloned into the pET-28a(+) vector (Novagen) at BamHI/NdeI restriction sites, followed by transformation into *Escherichia coli* BL21(DE3). Expression of CALNUC protein was induced with 1 mM isopropyl β-[d]{.smallcaps}-thiogalactoside (IPTG) (Pharmacia Biotech) at 18°C for 4 h at a bacterial density of OD~600~ ≥ 1.0.

To purify His6-CALNUC protein, transformed *E*. *coli* were suspended in binding buffer containing 20 mM sodium phosphate and 500 mM NaCl (pH 7.5), and sonicated using a Microson Ultrasonic Cell Disrupter (Heat Systems). Lysates were incubated with Ni-NTA agarose (Qiagen), washed with 20 mM sodium phosphate, 500 mM NaCl at decreasing pH (8.0, 6.0, and 5.3), and bound proteins were sequentially eluted with an imidazole step gradient (10 mM to 1 M). Fractions containing a single band of purified CALNUC detected by silver staining were pooled and dialyzed against TBS containing 150 mM NaCl and 10 mM Tris-HCl (pH 7.4) at 4°C, and subsequently concentrated using an Ultrafree-15 (Biomax-50K) filter (Millipore). Highly purified His6-CALNUC \[0.6 mg/liter of transformed BL21(DE3)\] was obtained.

Ca^2+^-binding Analysis
-----------------------

Equilibrium dialysis was performed essentially as previously published ([@B31]; [@B2]). Ca^2+^-free solution was prepared by treatment of deionized water with a UniPure I Water Purification System (Solution Consultants) and Chelex 100 ion exchange resin (Bio-Rad) ([@B49]). Equilibrium dialysis was performed using a Dialysis System (GIBCO BRL). 0.25 mg Ca^2+^-depleted CALNUC ([@B49]) was incubated with 0.35 μCi/ml ^45^CaCl~2~and different concentrations of cold Ca^2+^ at 4°C for 16 h, followed by assessment of radioactivity using a LS 6000IC Liquid Scintillation System (Beckman Instruments) in EcoLume liquid scintillation cocktail (ICN). Scatchard analysis was performed using CA Cricket Graph III software (Computer Associates International).

Primary Structure Comparison
----------------------------

Amino acid sequences of CALNUC, Cab45 ([@B45]), and calmodulin (CaM) were obtained through Entrez on the National Center for Biotechnology Information\'s (NCBI) World Wide Web home page. Alignment of EF-hand motifs was performed using MacVector 6.0 software (Oxford Molecular Groups-IBI).

Cell Culture
------------

HeLa cells were maintained in DME high glucose medium (Irvine Scientific) supplemented with 10% FCS (Life Technologies Inc.). Cells were used as 80% confluent monolayers for transfection. Transfected EcR-CHO cells were cultured in Ham\'s F12 medium (CORE Cell Culture Facility, University of California, San Diego, CA) with 10% FCS (Life Technologies), 250 μg/ml Zeocin (Invitrogen), and 750 μg/ml G418 sulfate (Calbiochem). All media contained 100 U/ml of penicillin G and 100 μg/ ml of streptomycin sulfate. NRK cells were cultured as previously described ([@B29]).

Transient Overexpression of CALNUC-Green Fluorescent Protein (GFP) or Truncated CALNUC-GFP in HeLa Cells
--------------------------------------------------------------------------------------------------------

CALNUC cDNA was amplified by PCR with the primers 5′-CGCGGATCCATGCCTACCTCTGTG-3′ and 5′-CCATGCCATGGCTAAATGCTGAGAATCC-3′. GFP cDNA was also amplified by PCR with the primers 5′-TCATGCCATGGTGAGCAAGGG-3′ and 5′-ATAGTTTAGCGGCCGCTTACTTGTACAGCTC-3′. PCR products were purified and digested, respectively, with BamHI, NcoI, and NotI (New England Biolabs). CALNUC and GFP cDNA were subcloned into the pcDNA3 vector (Invitrogen) by three-fragment ligation to obtain a CALNUC-GFP/pcDNA3 construct with GFP ligated to the 3′ (COOH terminus) of CALNUC.

CALNUC(ΔEF-1), in which the α helix (Asp~227~--Leu~239~) of the first EF-hand (EF-1) domain (see Fig. [1](#F1){ref-type="fig"}) was deleted, was obtained by PCR with the primers 5′-CGCGGATCCATGCCTACCTCTGTG-3′/5′-CCCAAGCTTATGCAGTATGAAGAA-3′, and 5′-CCCAAGCTTGAAGCTCTGTTTACC-3′ / 5 ′ -CCATGCCATGGCTAAATGCTGAGAATCC-3 ′ . CALNUC(ΔEFs-1,2), in which both EF-1 and EF-2 domains (Asp~227~-- Phe~291~) (see Fig. [1](#F1){ref-type="fig"}) were deleted, was prepared with primers of 5′-CGCGGATCCATGCC TACC TCTGTG- 3 ′ / 5 ′ -CCCAAGCT TATGCAGTATGAAGAA-3′, and 5′-CCCAAGCTTCTGGCATCCACACAG-3′/5′-CCA- TGCCATGGCTAAATGCTGAGAATCC-3′. CALNUC mutants and the GFP tag were subcloned into the pcDNA3 vector by four-fragment ligation with HindIII and NcoI as internal restriction linker sites. Fidelity of the constructs was verified by automated DNA sequencing (CFAR, University of California, San Diego, CA). cDNA constructs were transformed into *E*. *coli* DH5α, followed by extraction and purification using QIAGEN Plasmid Midi/Mega Kits (Qiagen) and UltraPure CsCl (optical grade) (GIBCO BRL).

To express wild-type or truncated CALNUC-GFP in HeLa cells, 1 μg purified DNA was transfected into HeLa cells (33-mm dish, 80% confluence) using 6 μg lipofectamine (GIBCO BRL). Transfected cells were grown in serum and antibiotic-free high glucose DME medium for 5 h followed by replacement with regular culture medium.

Establishment of a Stable HeLa Cell Line Overexpressing GFP Using Flow Cytometry
--------------------------------------------------------------------------------

GFP cDNA amplified by PCR with the primers 5′-TCGCGGATCCATGGTGAGCAAGGG-3′ and 5′-ATAGTTTAGCGGCCGCTTACTTGTACAGCTC-3′ was subcloned into the pcDNA3 vector at BamHI/ NotI restriction sites, followed by transfection into HeLa cells as described above and G418 selection (0.75 mg/ml) for 4 d. Cells expressing GFP were sorted by flow cytometry (Ex/Em: 488/530 ± 15) (FACStar Plus^®^; Becton Dickinson) in the UCSD Flow Cytometry Core Facility. The top 0.12% of the positive cells was collected and maintained in media containing 0.75 mg/ml G418 until confluent. Selection by sorting was repeated three times until 100% of the cells (HeLa-GFP, GPH-1216) expressed GFP (data not shown).

Establishment of Stable Cell Lines Overexpressing CALNUC in the Ecdysone-inducible Mammalian Expression System
--------------------------------------------------------------------------------------------------------------

CALNUC cDNA was amplified by PCR and subcloned into the pIND vector (Invitrogen) at BamHI/NotI restriction sites. EcR-CHO cells (Invitrogen) stably expressing the ecdysone receptor (RxR and VgEcR) were transfected with CALNUC/pIND plasmid DNA using lipofectamine as described above followed by selection for G418 resistance (0.4 mg/ml) for 18 d. Cells were split into 96-well plates by serial dilution, 0.5 cells/well, and subsequently reselected with G418 (0.75 mg/ml). Four clones overexpressing CALNUC after induction with muristerone A (Invitrogen) were obtained; one of these, EcR-CHO-CALNUC-1 (CPC-22A), was used for these experiments.

Immunocytochemistry
-------------------

CALNUC-GFP was directly visualized using a Zeiss Axiophot microscope and an FITC-filter (Ex/Em: 485/510). For immunofluorescence, cells on coverslips were fixed with 2% paraformaldehyde (50 min), permeabilized with 0.1% Triton X-100 (10 min), and incubated with affinity-purified anti-CALNUC IgG (6 μg/ml), anti--Man II serum (1:300), or anticalnexin serum (1:100) as previously described ([@B29]). Detection was with Texas red-- or FITC-conjugated donkey anti--rabbit F(ab′)~2~. In some cases cells were doubly stained for CALNUC and either a mouse mAb against Man II (40 μg/ml) or the IP~3~R-1 (1.25 μg/ml) and appropriate secondary antibodies. Specimens were examined with either a Zeiss Axiophot equipped for epifluorescence or a Bio-Rad confocal microscopy (MRC 1024) equipped with Lasersharp 3.1 software (Bio-Rad) and a krypton-argon laser. Images were processed with Scion Image and Adobe Photoshop (Adobe Systems) software.

Subcellular Fractionation
-------------------------

Sucrose gradient flotation of Golgi fractions was carried out using a protocol similar to those previously published ([@B19]; [@B8]) with minor modifications. In brief, microsomal membranes were resuspended in 1.5 ml 55% sucrose (wt/wt), loaded at the bottom of a sucrose step gradient consisting of 40, 35, 30, 25, and 20% (wt/wt in 1 mM Tris-HCl, pH 7.5), and centrifuged at 85,500 *g* for 16 h at 4°C using a SW-40Ti rotor (Beckman). 20 fractions were collected from the bottom, followed by SDS-PAGE and immunoblotting for calnexin (an ER marker), Man II (a Golgi marker), and CALNUC.

Rat liver Golgi fractions, membrane (100,000 *g* pellet) and cytosolic (100,000 *g* supernatant) fractions were prepared from postnuclear supernatants of transfected HeLa or EcR-CHO-CALNUC cells as previously described ([@B44]; [@B27]; [@B29]).

Immunoblotting and SDS-PAGE
---------------------------

Proteins were separated by 5 or 10% SDS-PAGE, transferred to PVDF membranes, and immunoblotted with affinity-purified anti-CALNUC IgG, anticalnexin, and anti--Man II serum followed by HRP-conjugated anti--rabbit IgG and detection by ECL ([@B29]).

^45^Ca^2+^ Equilibrium Uptake and Release
-----------------------------------------

The procedures followed were those reported previously ([@B3]). Cells (2 × 10^6^) transfected with CALNUC-GFP or GFP alone were incubated with ^45^Ca^2+^ (2 μCi/ml) for 48 h to reach ^45^Ca^2+^ equilibrium after which they were washed three times in Krebs-Ringer-Hepes (KRH) buffer (125 mM NaCl, 5 mM KCl, 1.2 mM KH~2~PO~4~, 1.2 mM MgSO~4~, 2 mM CaCl~2~, 6 mM glucose, and 25 mM Hepes, pH 7.4) and five times with PBS. ^45^Ca^2+^ was extracted with 0.1 N HCl (30 min at room temperature) and radioactivity assessed as described above. To examine ^45^Ca^2+^ release after stimulation, washed cells were resuspended in KRH supplemented with 3 mM EGTA and stimulated at room temperature with 100 μM ATP or sequentially stimulated with 0.1 μM Tg, 2 μM ionomycin, and 2 μM monensin, 5 min each. Equal aliquots (10^6^ cells) were collected after each stimulation, followed by centrifugation at 14,000 rpm (30 s) and quantification of ^45^Ca^2+^ in the supernatant.

Ca^2+^ Imaging
--------------

Noninduced or induced EcR-CHO-CALNUC cells were loaded with 1 mM Fura-2 AM (Molecular Probes Inc.) in Ham\'s F12 medium/0.5% FCS at 22°C for 1 h, washed with Ca^2+^-free HBSS (Irvine Scientific) followed by addition of 100 μM ATP. Ca^2+^ release was monitored by Ca^2+^ imaging performed on a Zeiss Axiovert microscope equipped with a cooled charge-coupled CCD camera (Photometrics) and MetaFluor software (Universal Imaging). Dual-excitation ratio imaging was obtained using two excitation filters (340DF20 and 380DF20) (Omega Optical and Chroma Technology) mounted on a filter wheel (Lambda 10-2; Sutter Instruments), a 420DRLP dichroic mirror, and a 510DF80 emission filter.

Assessment and Mobilization of Stored Ca^2+^ by IP~3~in Permeabilized Cells
---------------------------------------------------------------------------

The procedures used were basically similar to those published ([@B5]; [@B12]) with minor modifications. To examine equilibrium ^45^Ca^2+^ uptake, EcR-CHO-CALNUC cells induced with 5 μM ponasterone A for 24 h in a 6-well culture plate (10^6^ cells/well) were permeabilized at 20°C for 4 min with saponin (50 μg/ml) in loading buffer (140 mM KCl, 20 mM NaCl, 2 mM MgCl~2~, 2 mM ATP, 0.1 mM EGTA, 20 mM Pipes, pH 6.80), and 0.13 μM free Ca^2+^ calculated for conditions of pH 6.80, at 20°C ([@B51]). Cells were washed four times with loading buffer and subsequently loaded with ^45^Ca^2+^ (10 μCi/ml) for various times (10--60 min). They were then rinsed five times with loading buffer (30 s), stored ^45^Ca^2+^ was extracted with 1 ml 0.1 N HCl for 30 min, and 0.5-ml aliquots were counted.

To investigate ^45^Ca^2+^ mobilization by IP~3~, induced and permeabilized EcR-CHO-CALNUC cells were loaded with 10 μCi/ml of ^45^Ca^2+^ as above for 45 min. After washing (five times over 1--1.5 min), cells were challenged with 10 μM IP~3~ ([d]{.smallcaps}-myo-inositol 1,4,5-trisphosphate potassium salt) in loading buffer, 1 ml/well. Solutions were collected at 2-min intervals, replaced with loading buffer containing IP~3~, and counted.

Results {#Results}
=======

Quantification of Endogenous CALNUC in Rat Liver Golgi Fractions and NRK Cells
------------------------------------------------------------------------------

To quantify endogenous CALNUC in rat liver Golgi fractions, a linear standard curve was obtained for purified His6-CALNUC (1.3--40 ng) by immunoblotting and densitometric analysis (data not shown). Endogenous CALNUC was found to be present in pooled Golgi light and heavy fractions from rat liver ([@B44]; [@B27]) at a concentration of 3.8 μg/mg Golgi protein, i.e., ∼0.4% of the total Golgi protein (includes both Golgi resident proteins and cargo in transit through the Golgi). NRK cells were found to have 0.02 μg CALNUC/ 10^6^ cells, or 2.5 × 10^5^ CALNUC molecules/NRK cell.

CALNUC EF-1 Is an Ideal EF-Hand Ca^2+^-binding Motif and Constitutes a High Affinity, Low Capacity Ca^2+^-binding Site
----------------------------------------------------------------------------------------------------------------------

An ideal EF-hand Ca^2+^-binding motif has an α helix-- loop--α helix structure in which oxygen ligands (O) provided by carboxy side chains of Asp (D)/Glu (E), carbonyl groups (C′O) of the peptide main chain and H~2~O constitute the Ca^2+^-binding site, and a hydrophobic amino acid (φ) and a Gly (G) are essential for Ca^2+^ binding ([@B28]; [@B6]). CALNUC and Cab45 ([@B45]) are the only EF-hand, Ca^2+^-binding proteins identified so far in the Golgi. Since their Ca^2+^-binding constants are not yet known, in order to predict and compare the Ca^2+^-binding properties of these two proteins, we compared the EF-hand primary structures of CALNUC (two EF-hands), Cab45 (six EF-hands), and CaM (four EF-hands). Cab45\'s and CaM\'s EF-hand motifs are similar ([@B45]), and CaM\'s Ca^2+^-binding properties have been well characterized.

As shown in Fig. [1](#F1){ref-type="fig"} A, CALNUC EF-1, Cab45 EF-2 and -5, and all four CaM EF-hand structures constitute ideal EF-hand motifs. CALNUC EF-1 and EF-2 are strikingly similar to CaM EF-4 and Cab45 EF-5, but CALNUC EF-2 has an Arg (R) instead of Gly at residue 6 (Fig. [1](#F1){ref-type="fig"} B). This suggests that CALNUC has only a single ideal EF-hand motif, EF-1.

To investigate the binding affinity of CALNUC for Ca^2+^, we performed equilibrium dialysis. Purified recombinant His6-CALNUC was used based on a report that recombinant calreticulin (CRT) was comparable to native CRT in its Ca^2+^-binding capability ([@B2]). Scatchard analysis of the binding curve (Fig. [1](#F1){ref-type="fig"} C) indicates that CALNUC binds Ca^2+^ with a high affinity binding constant (*K* ~d~ = 6.6 μM) and a low capacity, ∼1.1 μmol Ca^2+^/μmol protein, suggesting only one high affinity, low capacity Ca^2+^-binding site on CALNUC.

Overexpressed CALNUC Colocalizes with the Golgi Marker Man II
-------------------------------------------------------------

To further investigate Ca^2+^ binding to CALNUC in vivo, we expressed CALNUC-GFP by transient transfection in HeLa cells and generated an inducible cell line, EcR-CHO-CALNUC, stably expressing CALNUC. By immunoblotting, CALNUC-GFP (90 kD) was detected in transiently transfected HeLa cells but not in nontransfected cells (Fig. [2](#F2){ref-type="fig"} A). The majority of the CALNUC (∼85%) was associated with membranes (100,000 *g* pellet) and the remainder (15%) was present in the cytosolic fraction (100,000 *g* supernatant). Three additional bands (Fig. [2](#F2){ref-type="fig"} A), also visualized after in vitro translation (data not shown), were also seen. They could be products of protein degradation or mistranslated CALNUC retained in the cytosol. By immunofluorescence the distribution of CALNUC-GFP overlapped with that of the Golgi marker Man II (Fig. [3](#F3){ref-type="fig"} A), indicating that the majority of the CALNUC-GFP is correctly targeted to the Golgi.

In EcR-CHO-CALNUC cells induced with muristerone A or ponasterone A (0.1--10 μM) for 24 h, we found a linear increase in the expression of CALNUC with increasing amounts of added hormone (Fig. [2](#F2){ref-type="fig"} B). The ratio of CALNUC in membrane versus cytosolic fractions was similar to that of CALNUC-GFP in HeLa cells (data not shown). By immunofluorescence the distribution of CALNUC again overlapped with that of Man II in the Golgi region (Fig. [3](#F3){ref-type="fig"} C) in EcR-CHO-CALNUC cells induced with 10 μM muristerone A for 24 h, and was distinct from that of the ER marker, calnexin (Fig. [3](#F3){ref-type="fig"} B).

Cosedimentation of Overexpressed CALNUC and Man II in Sucrose Gradients
-----------------------------------------------------------------------

Next we analyzed the distribution of CALNUC in induced EcR-CHO-CALNUC cells using an established procedure for flotation of Golgi membranes and their separation from ER membranes. As shown in Fig. [4](#F4){ref-type="fig"}, we found that CALNUC and Man II cosedimented and peaked in fractions 12--15 with sucrose densities similar to those previously reported (1.10--1.14 g/ml) ([@B14]; [@B8]) for CHO cells. By contrast, the ER marker, calnexin, peaked in denser fractions 7--11 (1.16--1.19 g/ml). These results together with the immunofluorescence findings demonstrate that overexpressed CALNUC is found in the Golgi and is consistent with our previous conclusion ([@B29]) that overexpression does not lead to mistargeting of CALNUC.

Overexpression of CALNUC-GFP or CALNUC in the Golgi Increases ^45^Ca^2+^ Uptake
-------------------------------------------------------------------------------

To assess whether overexpressed CALNUC-GFP binds Ca^2+^ in the Golgi, we carried out in vivo equilibrium Ca^2+^ uptake. The ^45^Ca^2+^ loading time was ∼48 h, the time shown previously to be long enough to reach ^45^Ca^2+^ equilibrium in cultured cells ([@B33]). ^45^Ca^2+^ uptake by HeLa cells transiently overexpressing CALNUC-GFP was 2.5-fold that of nontransfected HeLa cells or those stably expressing GFP alone (Fig. [5](#F5){ref-type="fig"} A). Similarly, there was a threefold increase in ^45^Ca^2+^ taken up by induced (5 μM muristerone A for 48 h) versus noninduced EcR-CHO-CALNUC cells (Fig. [5](#F5){ref-type="fig"} B). These results demonstrate that Golgi-associated CALNUC binds Ca^2+^ in vivo and most likely is responsible for sequestering Ca^2+^ in the Golgi lumen.

To investigate whether EF-1 is indeed the sole Ca^2+^-binding motif in CALNUC, we examined Ca^2+^ binding in HeLa cells transiently transfected with truncated CALNUC-GFP mutants. When the α helix of EF-1 (Asp~227~-- Leu~239~) or both EF-1 and EF-2 (Asp~227~--Phe~291~) were deleted from CALNUC, its Ca^2+^-binding capability was completely abolished (Fig. [5](#F5){ref-type="fig"} A). Mistargeting could be ruled out since the majority of the mutant CALNUC-GFP was detected in the Golgi region by fluorescence. The results obtained from this in vivo Ca^2+^-binding analysis provide direct evidence that CALNUC binds Ca^2+^ in the Golgi, and EF-1 constitutes the sole Ca^2+^-binding site on CALNUC. The latter is in agreement with the data shown in Fig. [1](#F1){ref-type="fig"}.

Release of Sequestered ^45^Ca^2+^ by the SERCA Inhibitor, Tg
------------------------------------------------------------

To further investigate the characteristics of the Golgi Ca^2+^ pool, we performed experiments similar to those done previously to characterize the ER Ca^2+^ pool in cells overexpressing CRT ([@B3]; [@B33]). When HeLa cells transiently overexpressing CALNUC-GFP or EcR-CHO-CALNUC cells stably expressing CALNUC were treated with the SERCA inhibitor Tg ([@B48]), ∼73% and 70%, respectively, of the ^45^Ca^2+^ was released (Fig. [6](#F6){ref-type="fig"}), suggesting the existence of SERCA on Golgi membranes. Since some Tg-insensitive organelles are capable of retaining Ca^2+^ after Tg treatment, we subsequently treated cells with the Ca^2+^ ionophore ionomycin to release the remaining stored ^45^Ca^2+^. Nearly all the remaining ^45^Ca^2+^ (∼20--25%) was released by ionomycin (Fig. [6](#F6){ref-type="fig"}). In view of the fact that ionomycin is inactivated in acidic compartments such as secretory granules and endosomes, we further treated cells with monensin, a carboxylic sodium proton ionophore which releases Ca^2+^ from acidic compartments ([@B3]; [@B33]) and found \<5% of the ^45^Ca^2+^ was released. Cells overexpressing CALNUC-GFP or induced EcR-CHO-CALNUC cells released twice as much ^45^Ca^2+^ as nontransfected HeLa cells, HeLa cells stably expressing GFP alone, or noninduced EcR-CHO-CALNUC cells. The fact that the majority of the ^45^Ca^2+^ taken up by CALNUC was released by Tg suggests that both CALNUC and SERCA play a key role in sequestering ^45^Ca^2+^ in the Golgi, a conclusion in agreement with the recent description of SERCA associated with isolated Golgi fractions ([@B47]).

Release of Sequestered Ca^2+^ from the Golgi by Extracellular ATP
-----------------------------------------------------------------

We next examined whether or not Ca^2+^ sequestered in the Golgi is released after agonist challenge. Extracellular ATP is known to activate phospholipase C (PLC) ([@B7]) via binding to G protein--coupled nucleotide receptors on the cell surface ([@B38]). Activated PLC promotes production of IP~3~which binds to IP~3~R on the ER and triggers Ca^2+^ mobilization. To investigate whether Ca^2+^ sequestered by overexpressed CALNUC in the Golgi could be released by agonist, we examined Ca^2+^ release in EcR-CHO-CALNUC cells by Ca^2+^ imaging after ATP challenge. The results (Fig. [7](#F7){ref-type="fig"} A) demonstrated that the ratio, 340:380, was doubled in cells induced with 2.5 μM ponasterone A for 24 h compared with noninduced cells, suggesting that more Ca^2+^ was released from induced cells. Similar results were also obtained when induced EcR-CHO-CALNUC cells were loaded with ^45^Ca^2+^ (Fig. [7](#F7){ref-type="fig"} B). These results obtained by two different methods suggest that the Golgi Ca^2+^ store is sensitive to IP~3~ generated after ATP binding.

Release of ^45^Ca^2+^ Sequestered in the Golgi by IP~3~
-------------------------------------------------------

To obtain direct evidence that IP~3~ is able to release Ca^2+^ from the Golgi, ^45^Ca^2+^ uptake and release studies were performed on permeabilized EcR-CHO-CALNUC cells. Fig. [8](#F8){ref-type="fig"} A reveals that ^45^Ca^2+^ is rapidly taken up by both induced and noninduced permeabilized cells, but approximately twice the amount of ^45^Ca^2+^ was sequestered by cells overexpressing CALNUC. Steady state was achieved 45 min after loading, which was slower than reported for Swiss 3T3 cells (20 min) ([@B5]). ^45^Ca^2+^ release was then stimulated by addition of IP~3~ (Fig. [8](#F8){ref-type="fig"} B). The ratio of ^45^Ca^2+^ released from induced versus noninduced cells was ∼2:1. These results support the previous report of Pinton and colleagues (1998) suggesting that both Golgi membranes and ER membranes bear IP~3~R.

Localization of the IP~3~ Receptor on the Golgi and ER by Immunofluorescence
----------------------------------------------------------------------------

In view of the functional evidence for the existence of IP~3~R on the Golgi, we carried out immunofluorescence studies on NRK cells and induced EcR-CHO-CALNUC cells using a mAb that recognizes IP~3~R-1. IP~3~R-1 was found throughout the cytoplasm and concentrated in the Golgi region (Fig. [3](#F3){ref-type="fig"} D) which is compatible with both an ER and Golgi localization. Confocal analysis (Fig. [3](#F3){ref-type="fig"} E) showed that the distribution of IP~3~R-1 overlaps with that of CALNUC in the juxtanuclear region, suggesting that IP~3~R-1 and CALNUC colocalize on Golgi membranes. As mentioned by Pinton and co-workers (1998), it was not possible to carry out reproducible immunogold localization by immunoelectron microscopy with the antibody available.

Discussion {#Discussion}
==========

The Golgi complex has been recently identified as a Ca^2+^-enriched compartment whose total Ca^2+^ concentration is \>0.1 mM ([@B9]; [@B40]; [@B41]), but the question of how Ca^2+^ is sequestered in the Golgi has remained unanswered. Previously we showed that CALNUC is the major Ca^2+^-binding protein in Golgi fractions from rat liver detected by ^45^Ca^2+^ overlay ([@B29]). In this study we provide evidence that CALNUC binds Ca^2+^ in the Golgi in vivo, because overexpression of CALNUC in the Golgi led to a two- to threefold increase in Ca^2+^ storage based on Ca^2+^ equilibrium loading. This suggests that CALNUC is directly involved in maintenance of Ca^2+^ storage and thereby in Ca^2+^ homeostasis in the Golgi. Equilibrium dialysis demonstrated the existence of only a single high affinity (*K* ~d~= 6.6 μM)/low capacity (∼1 mol Ca^2+^/mol protein) binding site on recombinant CALNUC. CALNUC\'s low Ca^2+^-binding capacity in the Golgi might be compensated for by its abundance (3.8 μg/mg Golgi protein).

The demonstration of a single, high affinity Ca^2+^-binding site is in keeping with the fact that CALNUC possesses two EF-hand motifs but only one, EF-1, has the structure expected for high affinity calcium binding. EF-2 has an Arg (R) instead of a Gly (G) at residue 6 of the EF-hand loop region. Arg is supposed to disrupt the EF-hand motif and abolish its Ca^2+^-binding capacity ([@B6]). CALNUC\'s EF-1 has the highest homology to the COOH-terminal EF-4 of CaM which constitutes the high affinity Ca^2+^-binding site of CaM ([@B10]). Moreover, the Ca^2+^-binding capability of CALNUC EF-1 was demonstrated previously by ^45^Ca^2+^ overlay on truncated CALNUC. When EF-2 was deleted, Ca^2+^ binding was maintained, but when both EF-1 and EF-2 were deleted, Ca^2+^-binding capability was lost ([@B35]). In this study, we further demonstrated that truncated CALNUC with either the EF-1 α helix (Asp~227--~Leu~239~) or both EF-1 and EF-2 domains (Asp~227~--Phe~291~) deleted lost Ca^2+^-binding capability completely. The majority of each of the CALNUC mutant proteins was still targeted to the Golgi region as monitored via the GFP tag. Collectively, these data suggest that EF-1 may constitute the sole high affinity Ca^2+^-binding site on CALNUC.

Characterization of the Ca^2+^ pool in HeLa and CHO cells overexpressing CALNUC provides several important new pieces of information. ^45^Ca^2+^ sequestered in the Golgi in cells overexpressing CALNUC was largely released by Tg, an irreversible inhibitor of the SERCA Ca^2+^ pump, providing in vivo evidence for the existence of SERCAs on Golgi membranes. SERCAs were also assumed to be localized on Golgi membranes because it was shown previously that the p-type, Tg-sensitive SERCA Ca^2+^ pump was essential for Ca^2+^ uptake into isolated Golgi fractions in vitro ([@B47]). Our results also suggest that the increase in ^45^Ca^2+^ uptake in cells overexpressing CALNUC is not likely to be due to the presence of CALNUC in the cytosol or another recently reported Tg- and IP~3~-insensitive Ca^2+^ pool ([@B42]) since the majority of the Ca^2+^ was released only after SERCA was inhibited.

Our finding that only a small amount of the Ca^2+^ remaining after Tg treatment was released by subsequent ionomycin treatment might be due to incomplete depletion of Ca^2+^ from the Golgi by Tg, since the existence of a Tg-insensitive/ionomycin-sensitive--plasma membrane calcium ATPase Ca^2+^ pump on Golgi membranes has also been reported recently ([@B47]). The fact that monensin treatment which depletes Ca^2+^ from acidic compartments (secretory vesicles, granules, trans-Golgi network) ([@B17]) did not release a significant amount of Ca^2+^ demonstrates that Ca^2+^ was not sequestered in an acidic compartment. Thus, our current results from in vivo studies suggest that the Ca^2+^-binding protein CALNUC together with SERCA Ca^2+^ pumps are responsible for the maintenance of the Golgi Ca^2+^ storage pool.

We also investigated the agonist sensitivity of the Golgi Ca^2+^ pool. It was shown recently that the Golgi Ca^2+^ store is sensitive to histamine, an agonist known to be coupled to IP~3~ generation ([@B41]), suggesting that there may be IP~3~R on Golgi membranes. Here we used extracellular ATP, another agonist known to generate IP~3~ after binding to plasma membrane nucleotide receptors (P~2y~-purinoceptors) ([@B38]), to investigate the sensitivity of the Golgi Ca^2+^ store to IP~3~. ATP challenge is coupled to IP~3~ production via activation of PLC ([@B7]), and binding of IP~3~ to IP~3~R on the surface of Ca^2+^ pool releases intracellular Ca^2+^ ([@B25]). When ATP was added to induced EcR-CHO-CALNUC cells, there was a rapid release of sequestered Ca^2+^ revealed by both Ca^2+^ imaging and ^45^Ca^2+^ which far exceeded that released from noninduced cells. Moreover, IP~3~ directly triggered ^45^Ca^2+^ mobilization from the Golgi in permeabilized EcR-CHO-CALNUC cells. Thus, our biochemical results and those of [@B41] using histamine as agonist suggest that the Golgi apparatus bears IP~3~R. The assumption that IP~3~R are expressed on the Golgi is supported by our immunofluorescence observations suggesting a dual localization of IP~3~R-1 on both ER and Golgi membranes. CHO cells were found previously to express ample IP~3~R-1 by immunoprecipitation ([@B36]) using mAb 18A10 ([@B20]) which specifically recognizes the COOH terminus of IP~3~R-1.

A major controversy in the physiology of intracellular Ca^2+^ stores concerns the mechanism by which their depletion triggers influx of Ca^2+^ through the plasma membrane. In vertebrate cells, it has been assumed generally that the relevant store is the ER ([@B43]; [@B39]). However, because both ER and Golgi accumulate Ca^2+^ via SERCAs and release Ca^2+^ via IP~3~ receptors, both should undergo depletion roughly in parallel, so one cannot yet exclude a role for the Golgi in controlling plasma membrane Ca^2+^ influx. In yeast, store-operated Ca^2+^ influx appears to be controlled mainly at the Golgi, because genetic deletion of the Golgi Ca^2+^ pump encoded by *PMR1* increases the influx of extracellular Ca^2+^ ([@B22]). Therefore, we tried to distinguish between ER and Golgi contributions by testing whether overexpression of CALNUC in *Xenopus* oocytes affected the store-operated Ca^2+^ current, Isoc ([@B55]). If the Golgi were important, increasing the quantity of Ca^2+^ buffer in its lumen should diminish or delay Isoc ([@B33]; [@B18]). Overexpression of CALNUC (via microinjection of its mRNA) increased the ^45^Ca^2+^ content of oocytes analogously with Fig. [5](#F5){ref-type="fig"} and appeared by fluorescence microscopy to be colocalized with the Golgi marker galactosyltransferase fused to GFP ([@B30]). However, CALNUC overexpression did not significantly affect Isoc, either partially activated by the membrane-permeant Ca^2+^ buffer TPEN ([@B1]; [@B24]) or maximally activated by the ionophore ionomycin. This negative result might seem to argue against a major role for the Golgi in controlling Ca^2+^ influx into oocytes, but a firm conclusion would require additional controls such as immunoelectron microscopic localization of CALNUC and evidence that comparable increases in ER buffering do affect Isoc.

Previously, we demonstrated significant homology between CALNUC and CRT and two conserved motifs, AY(I/A)EE and QRLX(Q/E)E(I/E)E, located in the C-domain of CRT (aa~337--341~and ~365--372~) ([@B29]). However, the homologous regions do not involve Ca^2+^-binding domains. CRT lacks EF-hand motifs but possesses a high affinity/low capacity and a low affinity (*K* ~d~ = 2 mM)/ high capacity (21 μmol Ca^2+^/μmol protein) Ca^2+^-binding site ([@B2]) constituted by clusters of ∼35 Asp (D)/Glu (E) located in CRT\'s C-domain. In the future it will be of interest to examine whether CALNUC can function like CRT, its ER-resident counterpart ([@B29]), to maintain a high Ca^2+^ concentration required for Golgi functions, e.g., sorting, lectin binding, budding, and concentration of cargo into regulated secretory granules.

In summary, this study demonstrates that CALNUC, an abundant Golgi resident protein and the major Golgi Ca^2+^-binding protein, together with SERCA Ca^2+^ pumps and IP~3~R are involved in the maintenance of the Ca^2+^ storage pool in the Golgi. Further investigation of several remaining intriguing questions including whether the binding of Ca^2+^ to CALNUC regulates membrane traffic or posttranslational processing events in the Golgi, should shed light on the biological functions of CALNUC and on the Golgi Ca^2+^ pool.
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CaM

:   calmodulin

CRT

:   calreticulin

GFP

:   green fluorescent protein

IP~3~R

:   inositol 1, 4, 5 trisphosphate receptor

Man II

:   α-mannosidase II

PLC

:   phospholipase C

SERCA

:   sarcoplasmic/ER calcium ATPase

Tg

:   thapsigargin

![CALNUC EF-1 is an ideal EF-hand Ca^2+^-binding motif. (A) Alignment of the EF-hand loop domains constituting the key Ca^2+^-binding sites in CALNUC, Cab45, and CaM. Consensus amino acids characteristic of ideal EF-hand motifs with oxygen atom--containing side chains (O), a hydrophobic amino acid (Φ), and Gly (G) are boxed. Amino acid numbering corresponding to each EF-hand is as follows: CALNUC (220--246 and 272-- 298, Z36277), Cab45 (103--129, 142--168, 201--227, 238--264, 283-- 309, 319--345, U45977), and CaM (14--40, 50--76, 87--113, 124--150, M26151). Numbers in parentheses refer to the amino acid positions and the GenBank accession numbers, respectively. (B) Primary structure of EF-hands in CALNUC, Cab45, and CaM. Sequence comparison shows that CALNUC EF-1 and EF-2 have the highest similarity to Cab45 EF-5 and CaM EF-4, except that CALNUC EF-2 has an Arg (R) instead of a Gly at residue 6 of the loop region. (C) Binding of Ca^2+^ to CALNUC is high affinity and low capacity. CALNUC binding to Ca^2+^ was examined by equilibrium dialysis. Scatchard analysis reveals the existence of one high affinity (*K* ~d~= 6.6 μM)/low capacity (∼1.1 μmol Ca^2+^/ μmol of protein) Ca^2+^-binding site on CALNUC. Results represent the average of values from six separate experiments performed in triplicate.](JCB9810051.f1){#F1}

![Biochemical analysis of CALNUC expression in transfected cells. (A) HeLa cells transiently transfected with CALNUC-GFP. By immunoblotting (50 μg protein), ∼85% of the CALNUC-GFP (90 kD) is associated with the membrane pellet (M), and the remaining 15% is found in the cytosolic fraction (Cyt). No signal was detected in nontransfected HeLa cells (N.T.) when the same amount of protein was examined. HeLa cells transfected with CALNUC-GFP cDNA (48 h) were homogenized and membrane (100,000 *g* pellet) and cytosolic (100,000 *g* supernatant) fractions were prepared from the postnuclear supernatant. The pellet was resuspended in the same volume as the supernatant, and equal volumes of the membrane and cytosolic fractions were analyzed by SDS-PAGE and immunoblotted with affinity-purified anti-CALNUC IgG. (B) Expression of CALNUC in inducible, stably transfected EcR-CHO-CALNUC cells. By immunoblotting increasing amounts of CALNUC were detected in cell lysates (80 μg) after induction with increasing amounts (0.5--10 μM) of muristerone A. Cells stably transfected with CALNUC were lysed in 1% Triton X-100. Lysates (80 μg) were separated by SDS-PAGE and immunoblotted with affinity-purified anti-CALNUC IgG.](JCB9810051.f2){#F2}

![(A--C) Overexpressed CALNUC is correctly targeted to the Golgi. (A) HeLa cells transiently expressing CALNUC-GFP. CALNUC-GFP is concentrated in the Golgi region where it partially overlaps with the Golgi marker Man II. Cells were fixed in paraformaldehyde, permeabilized, and incubated with anti--Man II serum followed by Texas red--conjugated donkey anti--rabbit F(ab′)~2~ as described in Materials and Methods. (B) Induced or noninduced EcR-CHO-CALNUC cells. Overexpressed CALNUC is concentrated in the Golgi region in the induced cells in a pattern distinct from that of the ER marker, calnexin. Virtually no signal is detected in noninduced cells. Induced (muristerone A, 10 μM for 24 h) or noninduced cells were labeled with affinity-purified anti-CALNUC or anticalnexin serum and processed as in A. (C) Double labeling of induced EcR-CHO-CALNUC cells with anti-CALNUC IgG and anti--Man II mAb. The distribution of overexpressed CALNUC overlaps with that of Man II in the Golgi. Detection was with Texas red--conjugated donkey anti--mouse IgG and FITC-conjugated donkey anti--rabbit IgG. (D) Codistribution of IP~3~R with both ER and Golgi. NRK cells coimmunostained as above with anti-CALNUC IgG and mAb anti--IP~3~R-1 (18A10). IP~3~R-1 has an ER-type distribution and also overlaps with CALNUC in the Golgi region. Analysis was carried out on whole cells. (E) Similar preparation of induced EcR-CHO-CALNUC cells analyzed by confocal microscopy, showing overlap of staining for IP~3~R and CALNUC. Bars, 10 μm.](JCB9810051.f3){#F3}

![CALNUC cosediments with Man II in sucrose gradients. Total microsomes prepared from induced EcR-CHO-CALNUC cells were subjected to sucrose gradient flotation (85,500 *g* for 16 h) as described in Materials and Methods. 20 fractions were collected from the bottom, followed by 5 or 10% SDS-PAGE and immunoblotting analysis. CALNUC peaked in fractions 12--15 where it cosedimented with the Golgi marker Man II, whereas the ER marker calnexin peaked in denser fractions 7--11.](JCB9810051.f4){#F4}

![Overexpression of CALNUC increases ^45^Ca^2+^ uptake. (A) Nontransfected HeLa cells (N.T.), or those stably transfected with GFP alone, or transiently expressing CALNUC-GFP or CALNUC-GFP deletion mutants were incubated with 2 μCi/ml ^45^Ca^2+^ for 48 h to reach ^45^Ca^2+^ equilibrium. ^45^Ca^2+^ uptake by cells overexpressing CALNUC-GFP was 2.5-fold (2,500 vs. 1,000 cpm) greater than that found in nontransfected cells or those expressing GFP alone. Truncated CALNUC in which both EF-1 \[CN(ΔEF-1)-GFP\] or EF-1 and EF-2 \[CN(ΔEF-1, 2)-GFP\] were deleted completely lost Ca^2+^-binding capability. (B) EcR-CHO cells stably transfected with CALNUC cDNA (EcR-CHO-CALNUC) were loaded with ^45^Ca^2+^ as in A. ^45^Ca^2+^ uptake in induced cells (10 μM muristerone A) was threefold that found in noninduced cells (7,400 vs. 2,500 cpm). Results (mean ± SD) represent the average of values obtained in three separate experiments performed in duplicate.](JCB9810051.f5){#F5}

![Most of the ^45^Ca^2+^ taken up by CALNUC in the Golgi is released by the SERCA inhibitor Tg. Cells were incubated with ^45^Ca^2+^ for 48 h as in Fig. [5](#F5){ref-type="fig"} and sequentially treated with 0.1 μM Tg, 2 μM ionomycin, and 2 μM monensin. ^45^Ca^2+^ release into the medium was measured after each treatment. (A) ∼73%, ∼20%, and 7% of the ^45^Ca^2+^ was released from HeLa cells transiently overexpressing CALNUC-GFP after Tg, ionomycin, and monensin treatments, respectively. Nontransfected HeLa cells (N.T.) or those stably expressing GFP alone did not release as much ^45^Ca^2+^ as HeLa cells overexpressing CALNUC-GFP. (B) Similar results (70%, 25%, and 5%) for Ca^2+^ release were obtained for induced (5 μm ponasterone A for 24 h) EcR-CHO-CALNUC cells following sequential treatment as above. Induced cells release twice as much ^45^Ca^2+^ as noninduced cells. Results (mean ± SD) represent the average of values obtained in three separate experiments performed in duplicate.](JCB9810051.f6){#F6}

![The Golgi Ca^2+^ pool is sensitive to stimulation with ATP. (A) Induced (2.5 μM ponasterone A for 24 h) or noninduced EcR-CHO-CALNUC cells were loaded with 1 μM Fura-2 AM for 1 h, followed by challenge with 100 μM ATP. Released Ca^2+^ was monitored by Ca^2+^ imaging. More Ca^2+^ was released after ATP stimulation from cells overexpressing CALNUC than from noninduced cells. Results represent the average of values from 14 induced cells and 15 noninduced cells. Reproducible results were obtained from experiments repeated twice. (B) Noninduced or induced EcR-CHO-CALNUC cells were loaded with ^45^Ca^2+^ (2 μCi/ml) for 48 h to reach ^45^Ca^2+^ equilibrium. Cells were washed and resuspended in KRH buffer supplemented with 3 mM EGTA, followed by stimulation with 100 μM ATP for 5 min at room temperature. Aliquots of 10^6^ cells were subsequently removed, the cells were sedimented, and ^45^Ca^2+^ in supernatants and pellets was assessed. Compared with noninduced cells, there was a twofold increase in the ^45^Ca^2+^ released in cells overexpressing CALNUC. Results (mean ± SD) represent the average of values obtained in three separate experiments performed in duplicate.](JCB9810051.f7){#F7}

![Ca^2+^ sequestered by CALNUC in the Golgi was released directly by IP~3~ treatment of permeabilized cells. (A) ^45^Ca^2+^ uptake. Noninduced or induced EcR-CHO-CALNUC cells (10^6^ cells/well) were permeabilized with 50 μg/ml saponin for 4 min, followed by loading with ^45^Ca^2+^ (10 μCi/ml) for the times indicated. Stored ^45^Ca^2+^ was extracted with 1 ml 0.1 N HCl for 30 min, and 0.5-ml aliquots were counted. Induced cells took up twice as much ^45^Ca^2+^ as noninduced cells. ^45^Ca^2+^ uptake reached equilibrium at ∼45 min after loading. (B) ^45^Ca^2+^ release. Induced or noninduced EcR-CHO-CALNUC cells (10^6^ cells/ well) were permeabilized and loaded with 10 μCi/ml of ^45^Ca^2+^ for 45 min to reach equilibrium and IP~3~ (10 μM) was added. Aliquots (10) were collected at 2-min intervals. Stored ^45^Ca^2+^ could be directly released by IP~3~. Twice as much ^45^Ca^2+^ was released from induced as noninduced cells. Results (mean ± SD) represent the average of values obtained in three separate experiments performed in duplicate.](JCB9810051.f8){#F8}
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